Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshiko Fukuda

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Scientific Reports|November 2, 2022
Characteristics of intermediate age-related macular degeneration with hyperreflective fociWataru Kikushima, Yoichi Sakurada, Atsushi Sugiyama, et al.
International Ophthalmology|June 9, 2020
Association of CRP levels with ARMS2 and CFH variants in age-related macular degenerationTaiyo Shijo, Yoichi Sakurada, Yoshiko Fukuda, et al.
Pharmaceuticals (Basel, Switzerland)|June 27, 2024
Association of Polyp Regression after Loading Phase with 12-Month Outcomes of Eyes with Polypoidal Choroidal VasculopathyMisa Kimura, Yoichi Sakurada, Yoshiko Fukuda, et al.
Scientific Reports|February 24, 2025
Caveolin 1 and 2 enhance the proliferative capacity of BCAM-positive corneal progenitorsYuzuru Sasamoto, Shoko Kiritoshi, Catherine A A Lee, et al.
Biological Psychiatry|October 31, 2006
Monoallelic and unequal allelic expression of the HTR2A gene in human brain and peripheral lymphocytesYoshiko Fukuda, Minori Koga, Makoto Arai, et al.
Scientific Reports|April 30, 2020
Genetic factors associated with response to as-needed aflibercept therapy for typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathySeigo Yoneyama, Yoichi Sakurada, Wataru Kikushima, et al.
Antimicrobial Agents and Chemotherapy|December 18, 2019
The Novel Arylamidine T-2307 Demonstrates <i>In Vitro</i> and <i>In Vivo</i> Activity against Candida aurisNathan P Wiederhold, Laura K Najvar, Rosie Jaramillo, et al.
The Journal of Antimicrobial Chemotherapy|December 2, 2015
The novel arylamidine T-2307 demonstrates in vitro and in vivo activity against echinocandin-resistant Candida glabrataNathan P Wiederhold, Laura K Najvar, Annette W Fothergill, et al.
Investigative Ophthalmology & Visual Science|November 4, 2025
MYEOV Is a Novel Marker of Differentiated Corneal EpitheliumYoshiko Fukuda, Chao Zhang, Bruce R Ksander, et al.
Antimicrobial Agents and Chemotherapy|June 12, 2019
The Novel Arylamidine T-2307 Selectively Disrupts Yeast Mitochondrial Function by Inhibiting Respiratory Chain ComplexesKohei Yamashita, Taiga Miyazaki, Yoshiko Fukuda, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Scientific Reports|November 2, 2022
Characteristics of intermediate age-related macular degeneration with hyperreflective fociWataru Kikushima, Yoichi Sakurada, Atsushi Sugiyama, et al.
International Ophthalmology|June 9, 2020
Association of CRP levels with ARMS2 and CFH variants in age-related macular degenerationTaiyo Shijo, Yoichi Sakurada, Yoshiko Fukuda, et al.
Pharmaceuticals (Basel, Switzerland)|June 27, 2024
Association of Polyp Regression after Loading Phase with 12-Month Outcomes of Eyes with Polypoidal Choroidal VasculopathyMisa Kimura, Yoichi Sakurada, Yoshiko Fukuda, et al.
Scientific Reports|February 24, 2025
Caveolin 1 and 2 enhance the proliferative capacity of BCAM-positive corneal progenitorsYuzuru Sasamoto, Shoko Kiritoshi, Catherine A A Lee, et al.
Biological Psychiatry|October 31, 2006
Monoallelic and unequal allelic expression of the HTR2A gene in human brain and peripheral lymphocytesYoshiko Fukuda, Minori Koga, Makoto Arai, et al.
Scientific Reports|April 30, 2020
Genetic factors associated with response to as-needed aflibercept therapy for typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathySeigo Yoneyama, Yoichi Sakurada, Wataru Kikushima, et al.
Antimicrobial Agents and Chemotherapy|December 18, 2019
The Novel Arylamidine T-2307 Demonstrates <i>In Vitro</i> and <i>In Vivo</i> Activity against Candida aurisNathan P Wiederhold, Laura K Najvar, Rosie Jaramillo, et al.
The Journal of Antimicrobial Chemotherapy|December 2, 2015
The novel arylamidine T-2307 demonstrates in vitro and in vivo activity against echinocandin-resistant Candida glabrataNathan P Wiederhold, Laura K Najvar, Annette W Fothergill, et al.
Investigative Ophthalmology & Visual Science|November 4, 2025
MYEOV Is a Novel Marker of Differentiated Corneal EpitheliumYoshiko Fukuda, Chao Zhang, Bruce R Ksander, et al.
Antimicrobial Agents and Chemotherapy|June 12, 2019
The Novel Arylamidine T-2307 Selectively Disrupts Yeast Mitochondrial Function by Inhibiting Respiratory Chain ComplexesKohei Yamashita, Taiga Miyazaki, Yoshiko Fukuda, et al.
Pageof 7